Triazole Benzene Sulfonamides as Leads for Human Carbonic Anhydrase IX Inhibition: Updates on Research Progress

Journal Title: Der Pharma Chemica - Year 2024, Vol 16, Issue 2

Abstract

Introduction: Triazole moiety is considered as the most important heterocyclic therapeutic agent in medicinal chemistry. Identifying a lead compound or potential drug, with the requisite physical and biological characteristics from a library of known bioactive molecules is the first step in the traditional drug development process which involves identifying the protein target associated with the disease. This severely restricts the search space from the outset and makes the task of discovering new drugs (or novel chemical structures) very challenging. Areas covered: This review discusses triazole derivatives possessing anticancer activity (hCA inhibition) and also illustrates the recent updates on triazole moiety for hCA inhibition research emphasizing the structure activity relationship aspects. Conclusion: However, as the cellular and molecular causes of numerous diseases are better understood, more opportunities for logical therapeutic development broaden. Small molecule inhibitors of hCA IX interactions can now be found through screenings using large virtual chemical libraries and a series of novel compounds from research literature. In this context, the literature's triazole benzene sulfonamide derivatives have been thoroughly studied for structure-activity relationship and reported here for future design and development of leads.

Authors and Affiliations

Papichettypalle Gopinath

Keywords

Related Articles

Current Trends and Glimpse for All Pharma Global Regulatory Agencies Requirements of Nitrosamine and NDSRIs Impurities in Pharmaceuticals

The USFDA and EMEA announced in July 2018 that N-Nitroso Dimethylamine and N-N-NDMA are concentrated on pharmaceutical medicinal products and specifically used in case of SARTANS that are used in the treatment of hyperte...

Protein Assembly: An Understanding and Clarification

Alzheimer's disease is characterized by the accumulation of mis folded proteins that form fibrillary amyloid deposits in specific regions of the central nervous system. This leads to memory loss, changes in personality,...

The Effects of Bioactive Components Derived from Fruit on Different Types of Cancer: Mechanistic Pathways and Settings Associated to Stress

Background: Cancer is the world's leading cause of death today. Cancer patients' outcomes have significantly improved as surgery, radiotherapy and pharmaceuticals have advanced. Main body: fortunately the basic mechanism...

A Catalyst Free Simple and Efficient One Pot Synthesis of N-benzyloxazolidinone Derivatives

An efficient and catalyst free one pot synthesis of N-benzyloxazolidinone derivatives is developed by reaction of N-benzyl-β-amino alcohol derivatives and N, N-Carbonyldiimidazole (CDI) in DMSO. A range of novel N-benzyl...

Requalification of Friability Testing Apparatus

Re-qualification as a part of validation is the task performed to identify or check that utilities, equipment and ancillary systems can operate within limits for their intended use. Equipment qualification is a key eleme...

Download PDF file
  • EP ID EP742509
  • DOI 10.4172/0975-413X.16.2.274-282
  • Views 26
  • Downloads 0

How To Cite

Papichettypalle Gopinath (2024). Triazole Benzene Sulfonamides as Leads for Human Carbonic Anhydrase IX Inhibition: Updates on Research Progress. Der Pharma Chemica, 16(2), -. https://europub.co.uk/articles/-A-742509